Chicago Capital’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-125,636
| Closed | -$30.9M | – | 242 |
|
|
2022
Q3 | $30.9M | Buy |
125,636
+2,663
| +2% | +$654K | 1.79% | 21 |
|
|
2022
Q2 | $30.4M | Sell |
122,973
-30,791
| -20% | -$7.62M | 1.68% | 24 |
|
|
2022
Q1 | $50.9M | Buy |
153,764
+1,746
| +1% | +$578K | 2.19% | 16 |
|
|
2021
Q4 | $54.6M | Sell |
152,018
-2,109
| -1% | -$757K | 2.03% | 21 |
|
|
2021
Q3 | $50.2M | Sell |
154,127
-779
| -0.5% | -$254K | 1.9% | 24 |
|
|
2021
Q2 | $48.3M | Buy |
154,906
+4,679
| +3% | +$1.46M | 1.89% | 23 |
|
|
2021
Q1 | $47.9M | Buy |
150,227
+55,688
| +59% | +$17.7M | 2.02% | 21 |
|
|
2020
Q4 | $30.7M | Buy |
94,539
+12,881
| +16% | +$4.18M | 1.37% | 33 |
|
|
2020
Q3 | $22.6M | Buy |
81,658
+34,460
| +73% | +$9.55M | 1.16% | 34 |
|
|
2020
Q2 | $11.4M | Sell |
47,198
-15,054
| -24% | -$3.64M | 0.66% | 43 |
|
|
2020
Q1 | $9.04M | Sell |
62,252
-16,195
| -21% | -$2.35M | 0.73% | 42 |
|
|
2019
Q4 | $13.4M | Buy |
78,447
+13,497
| +21% | +$2.3M | 0.82% | 44 |
|
|
2019
Q3 | $11.6M | Sell |
64,950
-5,740
| -8% | -$1.02M | 0.77% | 46 |
|
|
2019
Q2 | $18.4M | Buy |
70,690
+4,042
| +6% | +$1.05M | 1.18% | 39 |
|
|
2019
Q1 | $19M | Sell |
66,648
-57
| -0.1% | -$16.3K | 1.29% | 34 |
|
|
2018
Q4 | $21.7M | Buy |
66,705
+905
| +1% | +$294K | 1.77% | 26 |
|
|
2018
Q3 | $29.6M | Buy |
65,800
+5,137
| +8% | +$2.31M | 2.05% | 18 |
|
|
2018
Q2 | $24.8M | Sell |
60,663
-7,906
| -12% | -$3.23M | 2% | 15 |
|
|
2018
Q1 | $20M | Buy |
+68,569
| New | +$20M | 2.66% | 5 |
|